Jerry A. Molitor
- Immunology top 2%
- T-cell and Retrovirus Studies 2
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 3
- Systemic Lupus Erythematosus Research 3
-
- Systemic Sclerosis and Related Diseases 13
- Cancer Research top 5%
- NF-κB Signaling Pathways 3
- Hematology top 5%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Pulmonary Hypertension Research and Treatments 3
-
- Inflammatory Myopathies and Dermatomyositis 3
- Co-authors
- Dean W. BallardWilliam H. WalkerStefan DoerreW C GreeneDaniel E. FürstAnthony GerbinoChristopher H. GossPrakash Sista
- Journals
- Proceedings of the National Academy of Sciences (2 papers)PLoS ONE (2 papers)European Heart Journal - Cardiovascular Imaging (1 paper)
- Partner nations
- United StatesAustriaNorway
In The Last Decade
Jerry A. Molitor
27 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 1.1k
- Rheumatology 697
- Pathology and Forensic Medicine 573
- Cancer Research 397
- Hematology 280
Countries citing papers authored by Jerry A. Molitor
This map shows the geographic impact of Jerry A. Molitor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry A. Molitor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry A. Molitor more than expected).
Fields of papers citing papers by Jerry A. Molitor
This network shows the impact of papers produced by Jerry A. Molitor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry A. Molitor. The network helps show where Jerry A. Molitor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jerry A. Molitor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 119 | |
| 3 | 2021 | 3 | |
| 4 | 2016 | 92 | |
| 5 | 2015 | 5 | |
| 6 | 2011 | 54 | |
| 7 | 2008 | 82 | |
| 8 | 2008 | 102 | |
| 9 | 2008 | 17 | |
| 10 | 2008 | 146 | |
| 11 | 2008 | 124 | |
| 12 | 2008 | 8 | |
| 13 | 2007 | 105 | |
| 14 | Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)breakdown → | 2005 | 502 |
| 15 | 2005 | 7 | |
| 16 | 2002 | 1 | |
| 17 | 1994 | 2 | |
| 18 | 1991 | 105 | |
| 19 | 1990 | 306 | |
| 20 | 1987 | 30 |
About Jerry A. Molitor
Jerry A. Molitor is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology, having authored 28 papers that have together received 2.3k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Eosinophilic Disorders and Syndromes (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Systemic Lupus Erythematosus Research (3 papers), NF-κB Signaling Pathways (3 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Immunology (1.1k citations), Rheumatology (697 citations) and Pathology and Forensic Medicine (573 citations). Jerry A. Molitor has collaborated with scholars based in United States, Austria and Norway. Frequent co-authors include Dean W. Ballard, William H. Walker, Stefan Doerre, W C Greene, Daniel E. Fürst, Anthony Gerbino, Christopher H. Goss, Prakash Sista, Ryan T. Demmer and Nancy J. Peffer. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE, European Heart Journal - Cardiovascular Imaging, Annals of the Rheumatic Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.